HEC CJ PHARM (1558.HK)
| Previous Close | 9.050 |
| Open | 9.100 |
| Bid | 9.110 x 0 |
| Ask | 9.130 x 0 |
| Day's Range | 8.990 - 9.130 |
| 52 Week Range | 7.870 - 13.300 |
| Volume | |
| Avg. Volume | 2,286,755 |
| Market Cap | 8.025B |
| Beta (5Y Monthly) | 0.11 |
| PE Ratio (TTM) | 4.47 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Sep 29, 2020 |
| 1y Target Est | N/A |
- Simply Wall St.
Three Undiscovered Gems In Hong Kong With Strong Fundamentals
The Hong Kong market has experienced a mix of volatility and cautious optimism, with the Hang Seng Index recently gaining 0.85% despite broader concerns about global economic conditions. Amidst this backdrop, discerning investors may find opportunities in small-cap stocks that exhibit strong fundamentals and resilience. In the current environment, identifying stocks with solid financial health, consistent earnings growth, and robust business models can be particularly rewarding. Here are...
- Simply Wall St.
Undiscovered Gems in Hong Kong August 2024
Despite recent volatility in global markets, the Hong Kong market has shown resilience, with the Hang Seng Index gaining 0.85% amidst broader economic uncertainties. This environment presents a unique opportunity to explore lesser-known stocks that may offer significant potential for growth. When considering stocks in such a dynamic market, it's essential to look for companies with strong fundamentals and innovative strategies that can thrive despite external pressures.
